Advanced search
Publication Cover
Scandinavian Journal of Infectious Diseases Volume 40, 2008 - Issue 11-12
Submit an article Journal homepage
88
Views
32
CrossRef citations to date
0
Altmetric
Original Article

Reduction of fluconazole susceptibility of Candida albicans in APECED patients due to long-term use of ketoconazole and miconazole

Riina Rautemaa From the Department of Microbiology and Immunology, Haartman Institute, University of Helsinki,; Departments of Bacteriology, Helsinki University Hospital HUSLAB, Helsinki; Department of Oral and Maxillofacial Diseases, Helsinki University Hospital, Helsinki, FinlandCorrespondence[email protected]
,
Malcolm Richardson From the Department of Microbiology and Immunology, Haartman Institute, University of Helsinki,; Mycology, Helsinki University Hospital HUSLAB, Helsinki
,
Michael Pfaller Medical Microbiology Division, Department of Pathology, College of Medicine, University of Iowa, Iowa, USA
,
Jaakko Perheentupa Hospital for Children and Adolescents, Helsinki University Central Hospital, and University of Helsinki, Finland
&
Harri Saxén Hospital for Children and Adolescents, Helsinki University Central Hospital, and University of Helsinki, Finland
Pages 904-907 | Received 17 Apr 2008, Published online: 08 Jul 2009

References

  • Perheentupa J. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab 2006; 91: 2843–50
  • Collins SM, Dominguez M, Ilmarinen T, Costigan C, Irvine AD. Dermatological manifestations of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome. Br J Dermatol 2006; 154: 1088–93
  • Rautemaa R, Hietanen J, Niissalo S, Pirinen S, Perheentupa J. Oral and oesophageal squamous cell carcinoma: a complication or component of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED, APS-I). Oral Oncol 2007; 43: 607–13
  • Sitheeque MA, Samaranayake LP. Chronic hyperplastic candidosis/candidiasis (candidal leukoplakia). Crit Rev Oral Biol Med 2003; 14: 253–67
  • Fan-Havard P, Capano D, Smith SM, Mangia A, Eng RH. Development of resistance in candida isolates from patients receiving prolonged antifungal therapy. Antimicrob Agents Chemother 1991; 35: 2302–5
  • Heald AE, Cox GM, Schell WA, Bartlett JA, Perfect JR. Oropharyngeal yeast flora and fluconazole resistance in HIV infected patients receiving long-term continuous versus intermittent fluconazole therapy. AIDS 1996; 10: 263–8
  • Rex JH, Rinaldi MG, Pfaller MA. Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 1995; 39: 1–8
  • Goldman M, Cloud GA, Smedema M, LeMonte A, Connolly P, McKinsey DS, et al. Does long-term itraconazole prophylaxis result in in vitro azole resistance in mucosal Candida albicans isolates from persons with advanced human immunodeficiency virus infection? The National Institute of Allergy and Infectious Diseases Mycoses study group. Antimicrob Agents Chemother 2000; 44: 1585–7
  • Smith KJ, Warnock DW, Kennedy CT, Johnson EM, Hopwood V, van Cutsem J, van den Bossche H. Azole resistance in Candida albicans. J Med Vet Mycol 1986; 24: 133–44
  • Rautemaa R, Richardson M, Pfaller M, Koukila-Kähkölä P, Perheentupa J, Saxén H. Decreased susceptibility of Candida albicans to azole antifungals: a complication of long-term treatment in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients. J Antimicrob Chemother 2007; 60: 889–92
  • Johnson EM, Richardson MD, Warnock DW. In vitro resistance to imidazole antifungals in Candida albicans. J Antimicrob Chemother 1984; 13: 547–58
  • Johnson EM, Warnock DW. Azole drug resistance in yeasts. J Antimicrob Chemother 1995; 36: 751–5
  • Fothergill AW. Miconazole: a historical perspective. Expert Rev Anti Infect Ther 2006; 4: 171–5
  • Akins RA. An update on antifungal targets and mechanisms of resistance in Candida albicans. Med Mycol 2005; 43: 285–318
  • Sanglard D, Odds FC. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis 2002; 2: 73–85
  • Kamai Y, Maebashi K, Kudoh M, Makimura K, Naka W, Uchida K, Yamaguchi H. Characterization of mechanisms of fluconazole resistance in a Candida albicans isolate from a Japanese patient with chronic mucocutaneous candidiasis. Microbiol Immunol 2004; 48: 937–43
  • Lamb DC, Kelly DE, Manning NJ, Kelly SL. Reduced intracellular accumulation of azole antifungal results in resistance in Candida albicans isolate NCPF 3363. FEMS Microbiol Lett 1997; 147: 189–93
  • Marichal P, Koymans L, Willemsens S, Bellens D, Verhasselt P, Luyten W, et al. Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans. Microbiology 1999; 145: 2701–13

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.